134 related articles for article (PubMed ID: 1510726)
1. Suicide inhibitors of cytochrome P450 1A1 and P450 2B1.
Hopkins NE; Foroozesh MK; Alworth WL
Biochem Pharmacol; 1992 Aug; 44(4):787-96. PubMed ID: 1510726
[TBL] [Abstract][Full Text] [Related]
2. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.
Roberts ES; Hopkins NE; Foroozesh M; Alworth WL; Halpert JR; Hollenberg PF
Drug Metab Dispos; 1997 Nov; 25(11):1242-8. PubMed ID: 9351899
[TBL] [Abstract][Full Text] [Related]
4. Determinants of protein modification versus heme alkylation: inactivation of cytochrome P450 1A1 by 1-ethynylpyrene and phenylacetylene.
Chan WK; Sui Z; Ortiz de Montellano PR
Chem Res Toxicol; 1993; 6(1):38-45. PubMed ID: 8448348
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.
Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF
Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo.
Thapliyal R; Maru GB
Food Chem Toxicol; 2001 Jun; 39(6):541-7. PubMed ID: 11346483
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic studies of 9-ethynylphenanthrene-inactivated cytochrome P450 2B1.
Roberts ES; Ballou DP; Hopkins NE; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1995 Nov; 323(2):303-12. PubMed ID: 7487092
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene.
Roberts ES; Hopkins NE; Zaluzec EJ; Gage DA; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1995 Nov; 323(2):295-302. PubMed ID: 7487091
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1-ethynylpyrene and related inhibitors of P450 isozymes upon benzo[a]pyrene metabolism by liver microsomes.
Hall M; Parker DK; Grover PL; Lu JY; Hopkins NE; Alworth WL
Chem Biol Interact; 1990; 76(2):181-92. PubMed ID: 2225228
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of loratadine as an inducer of liver microsomal cytochrome P450 in rats and mice.
Parkinson A; Clement RP; Casciano CN; Cayen MN
Biochem Pharmacol; 1992 May; 43(10):2169-80. PubMed ID: 1534660
[TBL] [Abstract][Full Text] [Related]
11. Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine.
Murray M
Biochem Pharmacol; 1992 Sep; 44(6):1219-22. PubMed ID: 1417944
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based inhibition of mouse P4502b-10 by selected arylalkynes.
Beebe LE; Roberts ES; Fornwald LW; Hollenberg PF; Alworth WL
Biochem Pharmacol; 1996 Nov; 52(10):1507-13. PubMed ID: 8937464
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of chick embryo hepatic cytochrome P450 1A, 2H and 3A following in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone.
McNamee JP; Kimmett SM; Marks GS
Biochem Pharmacol; 1995 May; 49(10):1443-52. PubMed ID: 7763287
[TBL] [Abstract][Full Text] [Related]
17. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.
He K; Falick AM; Chen B; Nilsson F; Correia MA
Chem Res Toxicol; 1996; 9(3):614-22. PubMed ID: 8728507
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetylenic and olefinic pyrenes upon cytochrome P-450 dependent benzo[a]pyrene hydroxylase activity in liver microsomes.
Gan LS; Lu JY; Hershkowitz DM; Alworth WL
Biochem Biophys Res Commun; 1985 Jun; 129(2):591-6. PubMed ID: 4015648
[TBL] [Abstract][Full Text] [Related]
19. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver.
Oetari S; Sudibyo M; Commandeur JN; Samhoedi R; Vermeulen NP
Biochem Pharmacol; 1996 Jan; 51(1):39-45. PubMed ID: 8534266
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
